When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ICCM - IceCure files application for approval of ProSense in Canada for tumors
IceCure Medical Ltd.
IceCure Medical ( NASDAQ: ICCM ) said on Monday it had submitted regulatory filing with the Canadian governmental agency for approval of its cancer killing device, ProSense System and its cryoprobes, to treat a number of cancers, including breast cancer, lung cancer, renal cell carcinoma and general surgery.
The ProSense System currently has regulatory approval for various indications in 14 countries, including in the U.S. and Europe, the company said.